146 related articles for article (PubMed ID: 11049803)
1. Controlled trials of amphotericin B lipid complex.
Boyle JA
Clin Infect Dis; 2000 Oct; 31(4):1117-8. PubMed ID: 11049803
[No Abstract] [Full Text] [Related]
2. Liposomal amphotericin B as antifungal prophylaxis in bone marrow transplant patients.
Falagas ME; Vardakas KZ
Am J Hematol; 2006 Apr; 81(4):299-300. PubMed ID: 16550510
[No Abstract] [Full Text] [Related]
3. [Amphotericin B. Lipid complex versus liposomes. Which, why, when?].
Pahissa A
Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):1-3. PubMed ID: 9147499
[No Abstract] [Full Text] [Related]
4. Controlled trials of amphotericin B lipid complex and other lipid-associated formulations.
Winston DJ; Schiller GJ
Clin Infect Dis; 2000 Jan; 30(1):236-7. PubMed ID: 10619780
[No Abstract] [Full Text] [Related]
5. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group.
Wingard JR; White MH; Anaissie E; Raffalli J; Goodman J; Arrieta A;
Clin Infect Dis; 2000 Nov; 31(5):1155-63. PubMed ID: 11073745
[TBL] [Abstract][Full Text] [Related]
6. Liposomal amphotericin B for fever and neutropenia.
Winston DJ; Schiller GJ; Territo MC
N Engl J Med; 1999 Oct; 341(15):1154-5. PubMed ID: 10515755
[No Abstract] [Full Text] [Related]
7. Liposomal amphotericin B for fever and neutropenia.
Rakita R
N Engl J Med; 1999 Oct; 341(15):1153-4; author reply 1154-5. PubMed ID: 10515754
[No Abstract] [Full Text] [Related]
8. [Safety of long-term administration of conventional amphotericin B in oncology patients].
Doubek M; Mayer J; Horký D
Cas Lek Cesk; 2002 Mar; 141(5):156-9. PubMed ID: 11998223
[TBL] [Abstract][Full Text] [Related]
9. Liposomal amphotericin B for fever and neutropenia.
Wingard JR
N Engl J Med; 1999 Oct; 341(15):1153; author reply 1154-5. PubMed ID: 10515753
[No Abstract] [Full Text] [Related]
10. A benefit for renal function after early switch to liposomal amphotericin B from conventional formulation in empirical antifungal treatment.
Isnard F; Tilleul P; Laporte JP; Chevallier P; Pigneux A; Lafuma A; Mahi L; Deray G
Nephrol Dial Transplant; 2007 Oct; 22(10):3090-1. PubMed ID: 17595189
[No Abstract] [Full Text] [Related]
11. Liposomal amphotericin B indicated for empirical therapy.
AIDS Patient Care STDS; 1997 Dec; 11(6):458-9. PubMed ID: 11361874
[No Abstract] [Full Text] [Related]
12. Liposomal amphotericin B for fever and neutropenia.
Prentice HG; Kibbler CC
N Engl J Med; 1999 Oct; 341(15):1152-3; author reply 1154-5. PubMed ID: 10515751
[No Abstract] [Full Text] [Related]
13. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
Borro JM; Solé A; de la Torre M; Pastor A; Fernandez R; Saura A; Delgado M; Monte E; Gonzalez D
Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
[TBL] [Abstract][Full Text] [Related]
14. Liposomal amphotericin B for fever and neutropenia.
Fischer T; Heussel G; Huber C
N Engl J Med; 1999 Oct; 341(15):1152; author reply 1154-5. PubMed ID: 10515750
[No Abstract] [Full Text] [Related]
15. Use of liposomal amphotericin B in bone marrow transplant.
Sastry PS; Parikh PM; Kulkarni PS; Bhagwat R; Gadade H
J Postgrad Med; 2005; 51 Suppl 1():S49-52. PubMed ID: 16519256
[TBL] [Abstract][Full Text] [Related]
16. Mortality rates in comparative trials of formulations of amphotericin B.
Frothingham R
Clin Infect Dis; 2001 Aug; 33(4):582-3. PubMed ID: 11462201
[No Abstract] [Full Text] [Related]
17. Amphotericin B deoxycholate: no significant advantage of a 24 h over a 6 h infusion schedule.
Altmannsberger P; Holler E; Andreesen R; Krause SW
J Antimicrob Chemother; 2007 Jul; 60(1):180-2. PubMed ID: 17537868
[No Abstract] [Full Text] [Related]
18. Trial design for mold-active agents: time to break the mold--aspergillosis in neutropenic adults.
Anaissie EJ
Clin Infect Dis; 2007 May; 44(10):1298-306. PubMed ID: 17443466
[No Abstract] [Full Text] [Related]
19. Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex.
Craddock C; Anson J; Chu P; Dodgson A; Duncan N; Gomez C; Mehta J; Sadullah S; Subudhi C; Yin JL
Expert Opin Drug Saf; 2010 Jan; 9(1):139-47. PubMed ID: 19947901
[TBL] [Abstract][Full Text] [Related]
20. Compassionate use protocol initiated for AmBisome.
J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):60. PubMed ID: 11363524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
